PART I Overview We are a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and other indications. Our POZ drug delivery technology is designed to enable certain existing drugs and novel drug candidates to be modified in a way that provides the potential to improve the integrated efficacy and safety profile of multiple modalities including small molecules, RNA-based therapeutics and antibody-based drug conjugates (ADC...
expected 2027-01-08
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-25 | 2025-12-31 | 0001708599-26-000016 | EDGAR | 81K words |
| 2025-03-24 | 2024-12-31 | 0001708599-25-000027 | EDGAR | 95K words |
| 2024-03-22 | 2023-12-31 | 0001493152-24-011022 | EDGAR | 116K words |
| 2023-03-31 | 2022-12-31 | 0001493152-23-010285 | EDGAR | 106K words |
| 2022-03-29 | 2021-12-31 | 0001493152-22-008028 | EDGAR | 100K words |
| 2021-03-31 | 2020-12-31 | 0001493152-21-007461 | EDGAR | 93K words |
| 2020-03-30 | 2019-12-31 | 0001493152-20-005309 | EDGAR | 94K words |
| 2019-04-01 | 2018-12-31 | 0001493152-19-004614 | EDGAR | 81K words |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-13 | 2026-06-30 | 0001708599-26-000047 | EDGAR | 21K words |
| 2025-11-13 | 2025-09-30 | 0001708599-25-000133 | EDGAR | 26K words |
| 2025-08-11 | 2025-06-30 | 0001708599-25-000089 | EDGAR | 21K words |
| 2025-05-08 | 2025-03-31 | 0001708599-25-000053 | EDGAR | 18K words |
| 2024-11-12 | 2024-09-30 | 0001708599-24-000026 | EDGAR | 28K words |
| 2024-08-09 | 2024-06-30 | 0001493152-24-030988 | EDGAR | 36K words |
| 2024-05-14 | 2024-03-31 | 0001493152-24-019248 | EDGAR | 32K words |
| 2023-11-14 | 2023-09-30 | 0001493152-23-041126 | EDGAR | 43K words |
| 2023-08-14 | 2023-06-30 | 0001493152-23-028478 | EDGAR | 32K words |
| 2023-05-12 | 2023-03-31 | 0001493152-23-016642 | EDGAR | 27K words |
| 2022-11-10 | 2022-09-30 | 0001493152-22-031357 | EDGAR | 30K words |
| 2022-08-12 | 2022-06-30 | 0001493152-22-022361 | EDGAR | 29K words |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-10-09 | 0001708599-26-000060 | EDGAR | 1K words |
| 2026-09-09 | 0001708599-26-000054 | EDGAR | 1K words |
| 2026-08-27 | 0001708599-26-000051 | EDGAR | 4K words |
| 2026-08-13 | 0001708599-26-000048 | EDGAR | 3K words |
| 2026-07-23 | 0001628280-26-049426 | EDGAR | 8K words |
| 2026-07-22 | 0001708599-26-000043 | EDGAR | 1K words |
| 2026-03-25 | 0001708599-26-000018 | EDGAR | 3K words |
| 2026-03-23 | 0001708599-26-000010 | EDGAR | 2K words |
| 2026-01-28 | 0001708599-26-000005 | EDGAR | 1K words |
| 2026-01-15 | 0001708599-26-000003 | EDGAR | 1K words |
201 total filings indexed. 171 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001708599 |
| Ticker | SER |
| Exchange | NYSE |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | AL |
| Website | https://www.serinatherapeutics.com |
| Listed | 2024-03-27 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/SER (~200 tokens, structured JSON with cryptographic provenance)